---
title: "PharmacoEconomics - Open: 12 recent papers (last 30 days)"
description: "PharmacoEconomics - Open published 12 papers in the last 30 days (2026-10-01 to 2026-10-30), ranking #82 of 392 journals."
url: https://scholar4ai.com/journals/pharmacoeconomics-open
markdown_url: https://scholar4ai.com/journals/pharmacoeconomics-open.md
license: CC BY-NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
share_text: "PharmacoEconomics - Open published 12 papers in the last 30 days (2026-10-01 to 2026-10-30), ranking #82 of 392 journals."
data_url: https://scholar4ai.com/data/rankings.json
updated: 2026-10-30T12:46:54+09:00
window: 2026-10-01 to 2026-10-30
source: OpenAlex (CC0)
---

# PharmacoEconomics - Open

- 4 papers in the last 7 days
- category: Health Economics and Policy
- publisher: Adis, Springer Healthcare
- ISSN 2509-4254

Back to the ranking: https://scholar4ai.com/rankings/journals.md

## Key findings

- PharmacoEconomics - Open published 12 papers in the last 30 days (2026-10-01 to 2026-10-30), ranking #82 of 392 journals.
- Leading institutions: The University of Queensland (2), Imperial College London (2) and Bocconi University (2).
- Countries: United States (5), United Kingdom (4) and Australia (2).
- From Oct 2023 to Sep 2026, PharmacoEconomics - Open published 237 papers (7 a month on average, by publication date in OpenAlex).
- Its most frequent keywords over that period were “cost-effectiveness” (89), “quality-adjusted life years” (74) and “health care costs” (41).
- Its most-cited paper of the period is “Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models” (2024-02-10), with 71 citations.
- Since October 2016, its most-cited paper is “National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison” (2021-01-10), with 114 citations.

## The last 36 months

*Papers by publication date, Oct 2023 to Sep 2026*

| Oct 23–Sep 24 | Oct 24–Sep 25 | Oct 25–Sep 26 | 36 months |
|---:|---:|---:|---:|
| 85 | 77 | 75 | 237 |

*Most frequent keywords, Oct 2023 to Sep 2026*

| # | Keyword | Papers |
|---:|---|---:|
| 1 | cost-effectiveness | 89 |
| 2 | quality-adjusted life years | 74 |
| 3 | health care costs | 41 |
| 4 | health technology assessment | 25 |
| 5 | Markov model | 24 |
| 6 | economic burden | 22 |
| 7 | health-related quality of life | 19 |
| 8 | cost-utility analysis | 16 |
| 9 | health utility | 16 |
| 10 | healthcare resource utilization | 15 |

*Most-cited papers published Oct 2023 to Sep 2026*

| # | Citations | Per month | Title | Journal | Published | Authors |
|---:|---:|---:|---|---|---|---|
| 1 | 71 | 2.2 | [Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models](https://doi.org/10.1007/s41669-024-00476-9) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2024-02-10 | Tim Reason, Emma Benbow, Julia Langham et al. |
| 2 | 54 | 2.0 | [A Systematic Review of the Impact of Spinal Cord Injury on Costs and Health-Related Quality of Life](https://doi.org/10.1007/s41669-024-00517-3) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2024-08-16 | Modou Diop, David Mark Epstein |
| 3 | 41 | 1.3 | [Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models](https://doi.org/10.1007/s41669-024-00477-8) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2024-02-10 | Tim Reason, William D. Rawlinson, Julia Langham et al. |
| 4 | 25 | 0.7 | [Developing a Natural History Model for Duchenne Muscular Dystrophy](https://doi.org/10.1007/s41669-023-00450-x) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2023-11-29 | Jonathan Broomfield, Micki Hill, F. Chandler et al. |
| 5 | 21 | 1.7 | [An Introduction to Costing and the Types of Costs Used within Health Economic Studies](https://doi.org/10.1007/s41669-025-00602-1) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2025-10-20 | Hugo C. Turner, Juan Carlos Rivillas, Shankar Prinja et al. |

## Most-cited since October 2016

*The journal's most-cited papers published since October 2016*

| # | Citations | Per month | Title | Journal | Published | Authors |
|---:|---:|---:|---|---|---|---|
| 1 | 114 | 1.6 | [National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison](https://doi.org/10.1007/s41669-020-00250-7) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2021-01-10 | Deepshikha Sharma, Arun Kumar Aggarwal, Laura Emily Downey et al. |
| 2 | 93 | 1.6 | [Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries](https://doi.org/10.1007/s41669-021-00311-5) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2021-11-29 | Anna-Maria Fontrier, Erica Visintin, Panos G. Kanavos |
| 3 | 90 | 1.4 | [Hospital Costs of Extracorporeal Membrane Oxygenation in Adults: A Systematic Review](https://doi.org/10.1007/s41669-021-00272-9) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2021-05-31 | Annemieke Oude Lansink‐Hartgring, Olivier van Minnen, Karin Marianne Vermeulen et al. |
| 4 | 87 | 1.0 | [A Nationwide Study of Prevalence Rates and Characteristics of 199 Chronic Conditions in Denmark](https://doi.org/10.1007/s41669-019-0167-7) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2019-07-24 | Michael Falk Hvidberg, Søren Paaske Johnsen, Michael Davidsen et al. |
| 5 | 79 | 1.2 | [Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?](https://doi.org/10.1007/s41669-020-00249-0) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2021-03-04 | Giancarlo Pruneri, Filippo de Braud, Anna Sapino et al. |
| 6 | 75 | 0.7 | [Health Technology Assessment for Policy Making in India: Current Scenario and Way Forward](https://doi.org/10.1007/s41669-017-0037-0) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2017-06-13 | Shankar Prinja, Laura Emily Downey, Vijay Kumar Gauba et al. |
| 7 | 71 | 2.2 | [Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models](https://doi.org/10.1007/s41669-024-00476-9) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2024-02-10 | Tim Reason, Emma Benbow, Julia Langham et al. |
| 8 | 66 | 0.6 | [Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls](https://doi.org/10.1007/s41669-018-0071-6) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2018-03-13 | Caroline C. Kingdon, Erinna W. Bowman, Hayley Curran et al. |
| 9 | 66 | 1.3 | [A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting](https://doi.org/10.1007/s41669-022-00361-3) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2022-08-23 | Conor McCloskey, María Toboso Ortega, Sunita Nair et al. |
| 10 | 63 | 0.6 | [Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review](https://doi.org/10.1007/s41669-017-0025-4) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2017-04-25 | Kabindra Regmi, Dinesh Kaphle, Sabina Timilsina et al. |

*Papers, newest first.*

| Date | Title | Journal | Authors | Affiliations |
|---|---|---|---|---|
| 2026-10-27 | [Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty](https://doi.org/10.1007/s41669-026-00696-1) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Nai-Chia Chen, Ash Bullement, Antal Tamás Zemplenyi et al. | University of Colorado Anschutz; University of York; Brigham and Women's Hospital; … |
| 2026-10-27 | [Initiating Patients on Peritoneal Dialysis Compared with In-Centre Haemodialysis in the United Kingdom: A Cost-Utility and Budget Impact Analysis](https://doi.org/10.1007/s41669-026-00692-5) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Tara Danying Li, C. Rinciog, Araadhna Sinha et al. | University of Sheffield; Keele University; Nottingham University Hospitals NHS Trust |
| 2026-10-26 | [Economic Evaluation of an E-Dengue Early Warning System for Proactive Dengue Prevention in the Mekong Delta Region, Vietnam: A Protocol](https://doi.org/10.1007/s41669-026-00691-6) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Trinh Manh Hung, Kim-Huong Nguyen, Hugo C. Turner et al. | The University of Queensland; Trinity College Dublin; Imperial College London; … |
| 2026-10-26 | [Quality-Adjusted and Disability-Adjusted Life Years (QALYs and DALYs): An Overview and Guide to Calculations](https://doi.org/10.1007/s41669-026-00678-3) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Hugo Turner, Brandon Wen Bing Chua, Panupong Chaowanasawat et al. | Imperial College London; Health Intervention and Technology Assessment Program; The University of Queensland; … |
| 2026-10-21 | [Hospital Burden and Care Pathways of ANCA-Associated Vasculitis in Italy: A Focus on Clinical, Economic, and Geographic Dimensions](https://doi.org/10.1007/s41669-026-00689-0) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Helen Banks, Giovanni Fattore, Claudio Jommi et al. | Bocconi University; Università degli Studi del Piemonte Orientale “Amedeo Avogadro”; Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia; … |
| 2026-10-13 | [Health State Valuation in Nigeria: An Insight into Discrete Choice Experiment-Based Preferences for Children and Adolescents from the Lenses of Adult Respondents](https://doi.org/10.1007/s41669-026-00690-7) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Abdulmuminu Isah, Iheomimichineke Ojiakor, Chinelo Obi et al. | University of Nigeria; Kenya Medical Research Institute; KEMRI-Wellcome Trust Research Programme; … |
| 2026-10-12 | [Conceptualising Health Economic Models Using a Graph Retrieval-Augmented, Agentic AI Framework with Human-in-the-Loop Validation: Proof-of-Concept Study](https://doi.org/10.1007/s41669-026-00687-2) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Tushar Srivastava, Hanan Irfan, Shilpi Swami |  |
| 2026-10-10 | [The Economic and Humanistic Burden of Phenylketonuria Among Patients and Their Caregivers: A Systematic Literature Review](https://doi.org/10.1007/s41669-026-00683-6) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Judit Józwiak‐Hagymásy, Tamás Zelei, Shailja Vaghela et al. | Syreon Research Institute (Hungary); Moderna Therapeutics (United States); Semmelweis University |
| 2026-10-05 | [Budget Impact Model of a Novel cfRNA Test-and-Treat Strategy for Preeclampsia in Advanced Maternal Age Pregnancies Compared with Current Guidelines](https://doi.org/10.1007/s41669-026-00682-7) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | April Zambelli-Weiner, Brian Harris Nathanson, Susan Hahn | Johns Hopkins University; Surrozen, Inc. (United States) |
| 2026-10-02 | [Generalized Pustular Psoriasis: A Cost-of-Illness and Health-Related Quality of Life Study in Italy](https://doi.org/10.1007/s41669-026-00684-5) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Ludovica Borsoi, Patrizio Armeni, Annalisa Maddalena Scopinaro et al. | Bocconi University; Azienda Ospedaliera Universitaria Integrata Verona |
| 2026-10-02 | [Cost-Effectiveness Analysis of Ribociclib plus an Aromatase Inhibitor (AI) Versus AI Alone in the Adjuvant Treatment of Stage II and III Pre- and Postmenopausal Women with HR+/HER2− Early Breast Cancer (EBC): A Canadian Payer Perspective](https://doi.org/10.1007/s41669-026-00674-7) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Dina Soliman, Christine Brezden‐Masley, Sandeep R. Sehdev et al. | Novartis (Canada); Mount Sinai Hospital; Ottawa Hospital |
| 2026-10-02 | [Healthcare Utilization and Direct Medical Costs of Hepatocellular Carcinoma Treatment — A German Claims Data Study of 2778 Patients](https://doi.org/10.1007/s41669-026-00685-4) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | Selina Becht, Sami Orabi, Simone Schrodi et al. | LMU Klinikum; Ludwig-Maximilians-Universität München; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie; … |

## Cite this page

Scholar4AI. (2026). PharmacoEconomics - Open. Journal Research Rankings. Retrieved October 30, 2026, from https://scholar4ai.com/journals/pharmacoeconomics-open

```bibtex
@misc{scholar4ai-journals-pharmacoeconomics-open,
  author = {{Scholar4AI}},
  title = {PharmacoEconomics - Open},
  year = {2026},
  howpublished = {\url{https://scholar4ai.com/journals/pharmacoeconomics-open}},
  urldate = {2026-10-30},
  note = {Journal Research Rankings; data from OpenAlex (CC0); licensed CC BY-NC 4.0}
}
```

License: CC BY-NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/).